Name Change Progress Update: I am delighted to announce the successful submission of all requisite documentation for the imminent name change to Category V Biotech, Inc. Presently, our team is actively engrossed in the pivotal process of securing approval from FINRA. This transition epitomizes our unwavering commitment to a future where innovation and biotechnology will unequivocally take center stage.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.